• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Healthful Plant-Based Diet Linked to Lower Total Stroke Risk
WEDNESDAY, March 10, 2021 -- A healthful plant-based diet is associated with a significantly reduced risk for total stroke, according to a study published online March 10 in Neurology. Megu Y. Baden, M.D., Ph.D., from the Harvard T. H. Chan School...
Source: Drugs.com - Pharma News - March 10, 2021 Category: Pharmaceuticals Source Type: news

Biosense Webster Unveils Late-Breaking Results from PRECEPT Study in Patients with Persistent Atrial Fibrillation
IRVINE, CA – May 8, 2020 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation Catheter, evaluated in the PRECEPT study for the treatment of persistent atrial fibrillation (AF), resulted in freedom from any documented, symptomatic atrial arrhythmias at 15 months post-procedure for eight out of ten study participants (80.4 percent).1 Use of the THERMOCOOL SMARTTOUCH SF CATHETER for persistent atrial fibrillation is investigational only. This PRECEPT study data support a Premarket Approval supplement application to the U.S. Food and Drug Adm...
Source: Johnson and Johnson - May 12, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Middle-Age Lifestyle Changes Can Cut Women ' s Stroke Risk
FRIDAY, April 10, 2020 -- Even in middle age, women can make lifestyle modifications that can substantially lower their stroke risk, according to a study published online April 9 in Stroke. Priyanka Jain, Sc.D., from the Harvard T.H. Chan School of...
Source: Drugs.com - Pharma News - April 10, 2020 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Launches Heartline ™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
New Brunswick, NJ, February 25, 2020 — Johnson & Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline™ Study, individuals must be age 65 or older...
Source: Johnson and Johnson - February 25, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

ReWalk looks to new 'exo-suit' to help it reach break-even
The so-called exo-suit uses a system of sensors, cables and other elements to give stroke victims with mobility issues "timed bursts of assistance" while walking, the founder of Harvard University's biodesign lab Conor Walsh said. The product presents a larger market opportunity for ReWalk, which has had difficulty growing its revenue over the last five years.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 4, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Depression Increases Stroke Risk Even After Symptoms Subside
While long term depression in adults older than 50 may double the risk of stroke, this risk still remains elevated--even when depressive symptoms ease up, according to a new study conducted at the Harvard School of Public Health.
Source: Forbes.com Healthcare News - May 16, 2015 Category: Pharmaceuticals Authors: Robert Glatter, MD Source Type: news